Keywords
Last Name
Institution

Mark Tykocinski

TitleEVP, Provost, Dean SKCC
InstitutionThomas Jefferson University
DepartmentSKMC - Senior Administration
Address1025 Walnut St.
Philadelphia PA 19107
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    R29CA047566     (TYKOCINSKI, MARK L)May 1, 1988 - Apr 30, 1993
    NIH/NCI
    HUMAN LEUKEMIC DIFFERENTIATION--ANTI-SENSE RNA STUDIES
    Role: Principal Investigator
    R01AI031044     (TYKOCINSKI, MARK L)Jul 1, 1992 - May 31, 2008
    NIH/NIAID
    Engineering Artifical Veto Cells
    Role: Principal Investigator
    R01AI038960     (TYKOCINSKI, MARK L)Feb 15, 1996 - Jan 31, 2006
    NIH/NIAID
    PLACENTAL PROTEIN 14 AS A UNIQUE IMMUNOREGULATOR
    Role: Principal Investigator
    R01CA069646     (TYKOCINSKI, MARK L)Sep 16, 1996 - Jun 30, 2000
    NIH/NCI
    H19 IN BLADDER CANCER
    Role: Principal Investigator
    R01CA074958     (TYKOCINSKI, MARK L)Sep 1, 1997 - Jul 31, 2008
    NIH/NCI
    CELLULAR CANCER VACCINES
    Role: Principal Investigator
    R03TW006148     (TYKOCINSKI, MARK L)Dec 15, 2002 - Nov 30, 2005
    NIH/FIC
    Placental Protein 14 as a Lectin-Like Immunomodulator
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Sanfilippo F, Powell D, Folberg R, Tykocinski M. Dealing With Deans and Academic Medical Center Leadership: Advice From Leaders. Acad Pathol. 2018 Jan-Dec; 5:2374289518765462. PMID: 29662949.
      View in: PubMed
    2. Romeo C, Weber MC, Zarei M, DeCicco D, Chand SN, Lobo AD, Winter JM, Sawicki JA, Sachs JN, Meisner-Kober N, Yeo CJ, Vadigepalli R, Tykocinski ML, Brody JR. HuR Contributes to TRAIL Resistance by Restricting Death Receptor 4 Expression in Pancreatic Cancer Cells. Mol Cancer Res. 2016 Jul; 14(7):599-611. PMID: 27053682.
      View in: PubMed
    3. Hojat M, Michalec B, Veloski JJ, Tykocinski ML. Can empathy, other personality attributes, and level of positive social influence in medical school identify potential leaders in medicine? Acad Med. 2015 Apr; 90(4):505-10. PMID: 25629944.
      View in: PubMed
    4. Michalec B, Veloski JJ, Hojat M, Tykocinski ML. Identifying potential engaging leaders within medical education: The role of positive influence on peers. Med Teach. 2014 Aug 26; 1-7. PMID: 25155553.
      View in: PubMed
    5. Aronin A, Amsili S, Prigozhina TB, Tzdaka K, Rachmilewitz J, Shani N, Tykocinski ML, Dranitzki Elhalel M. Fn14•TRAIL effectively inhibits hepatocellular carcinoma growth. PLoS One. 2013; 8(10):e77050. PMID: 24130833.
      View in: PubMed
    6. Martinez-Outschoorn UE, Pestell RG, Howell A, Tykocinski ML, Nagajyothi F, Machado FS, Tanowitz HB, Sotgia F, Lisanti MP. Energy transfer in "parasitic" cancer metabolism: mitochondria are the powerhouse and Achilles' heel of tumor cells. Cell Cycle. 2011 Dec 15; 10(24):4208-16. PMID: 22033146.
      View in: PubMed
    7. Orbach A, Rachmilewitz J, Shani N, Isenberg Y, Parnas M, Huang JH, Tykocinski ML, Dranitzki-Elhalel M. CD40·FasL and CTLA-4·FasL fusion proteins induce apoptosis in malignant cell lines by dual signaling. Am J Pathol. 2010 Dec; 177(6):3159-68. PMID: 21088216.
      View in: PubMed
    8. Ochanuna Z, Geiger-Maor A, Dembinsky-Vaknin A, Karussis D, Tykocinski ML, Rachmilewitz J. Inhibition of effector function but not T cell activation and increase in FoxP3 expression in T cells differentiated in the presence of PP14. PLoS One. 2010; 5(9):e12868. PMID: 20886106.
      View in: PubMed
    9. Razmara M, Hilliard B, Ziarani AK, Murali R, Yellayi S, Ghazanfar M, Chen YH, Tykocinski ML. Fn14-TRAIL, a chimeric intercellular signal exchanger, attenuates experimental autoimmune encephalomyelitis. Am J Pathol. 2009 Feb; 174(2):460-74. PMID: 19147815.
      View in: PubMed
    10. Razmara M, Hilliard B, Ziarani AK, Chen YH, Tykocinski ML. CTLA-4 x Ig converts naive CD4+CD25- T cells into CD4+CD25+ regulatory T cells. Int Immunol. 2008 Apr; 20(4):471-83. PMID: 18272926.
      View in: PubMed
    11. Tone Y, Furuuchi K, Kojima Y, Tykocinski ML, Greene MI, Tone M. Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat Immunol. 2008 Feb; 9(2):194-202. PMID: 18157133.
      View in: PubMed
    12. Orbach A, Rachmilewitz J, Parnas M, Huang JH, Tykocinski ML, Dranitzki-Elhalel M. CTLA-4 . FasL induces early apoptosis of activated T cells by interfering with anti-apoptotic signals. J Immunol. 2007 Dec 1; 179(11):7287-94. PMID: 18025171.
      View in: PubMed
    13. Tone Y, Kojima Y, Furuuchi K, Brady M, Yashiro-Ohtani Y, Tykocinski ML, Tone M. OX40 gene expression is up-regulated by chromatin remodeling in its promoter region containing Sp1/Sp3, YY1, and NF-kappa B binding sites. J Immunol. 2007 Aug 1; 179(3):1760-7. PMID: 17641042.
      View in: PubMed
    14. Dranitzki-Elhalel M, Huang JH, Sasson M, Rachmilewitz J, Parnas M, Tykocinski ML. CD40.FasL inhibits human T cells: evidence for an auto-inhibitory loop-back mechanism. Int Immunol. 2007 Apr; 19(4):355-63. PMID: 17314083.
      View in: PubMed
    15. Dranitzki-Elhalel M, Huang JH, Rachmilewitz J, Pappo O, Parnas M, Schmidt W, Tykocinski ML. CTLA-4.FasL inhibits allogeneic responses in vivo. Cell Immunol. 2006 Feb; 239(2):129-35. PMID: 16828466.
      View in: PubMed
    16. Ish-Shalom E, Gargir A, André S, Borovsky Z, Ochanuna Z, Gabius HJ, Tykocinski ML, Rachmilewitz J. alpha2,6-Sialylation promotes binding of placental protein 14 via its Ca2+-dependent lectin activity: insights into differential effects on CD45RO and CD45RA T cells. Glycobiology. 2006 Mar; 16(3):173-83. PMID: 16269626.
      View in: PubMed
    17. Crawford JM, Tykocinski ML. Pathology as the enabler of human research. Lab Invest. 2005 Sep; 85(9):1058-64. PMID: 16056243.
      View in: PubMed
    18. Mishan-Eisenberg G, Borovsky Z, Weber MC, Gazit R, Tykocinski ML, Rachmilewitz J. Differential regulation of Th1/Th2 cytokine responses by placental protein 14. J Immunol. 2004 Nov 1; 173(9):5524-30. PMID: 15494501.
      View in: PubMed
    19. Skornicka EL, Kiyatkina N, Weber MC, Tykocinski ML, Koo PH. Pregnancy zone protein is a carrier and modulator of placental protein-14 in T-cell growth and cytokine production. Cell Immunol. 2004 Nov-Dec; 232(1-2):144-56. PMID: 15882859.
      View in: PubMed
    20. Elhalel MD, Huang JH, Schmidt W, Rachmilewitz J, Tykocinski ML. CTLA-4. FasL induces alloantigen-specific hyporesponsiveness. J Immunol. 2003 Jun 15; 170(12):5842-50. PMID: 12794109.
      View in: PubMed
    21. Chen A, Zheng G, Tykocinski ML. Quantitative interplay between activating and pro-apoptotic signals dictates T cell responses. Cell Immunol. 2003 Feb; 221(2):128-37. PMID: 12747954.
      View in: PubMed
    22. Rachmilewitz J, Borovsky Z, Riely GJ, Miller R, Tykocinski ML. Negative regulation of T cell activation by placental protein 14 is mediated by the tyrosine phosphatase receptor CD45. J Biol Chem. 2003 Apr 18; 278(16):14059-65. PMID: 12556471.
      View in: PubMed
    23. Tykocinski ML, Chen A, Huang JH, Weber MC, Zheng G. New designs for cancer vaccine and artificial veto cells: an emerging palette of protein paints. Immunol Res. 2003; 27(2-3):565-74. PMID: 12857999.
      View in: PubMed
    24. Moody DB, Briken V, Cheng TY, Roura-Mir C, Guy MR, Geho DH, Tykocinski ML, Besra GS, Porcelli SA. Lipid length controls antigen entry into endosomal and nonendosomal pathways for CD1b presentation. Nat Immunol. 2002 May; 3(5):435-42. PMID: 11938350.
      View in: PubMed
    25. Rachmilewitz J, Borovsky Z, Mishan-Eisenberg G, Yaniv E, Riely GJ, Tykocinski ML. Focal localization of placental protein 14 toward sites of TCR engagement. J Immunol. 2002 Mar 15; 168(6):2745-50. PMID: 11884441.
      View in: PubMed
    26. Rachmilewitz J, Riely GJ, Huang JH, Chen A, Tykocinski ML. A rheostatic mechanism for T-cell inhibition based on elevation of activation thresholds. Blood. 2001 Dec 15; 98(13):3727-32. PMID: 11739178.
      View in: PubMed
    27. Zheng G, Chen A, Sterner RE, Zhang PJ, Pan T, Kiyatkin N, Tykocinski ML. Induction of antitumor immunity via intratumoral tetra-costimulator protein transfer. Cancer Res. 2001 Nov 15; 61(22):8127-34. PMID: 11719441.
      View in: PubMed
    28. Huang JH, Tykocinski ML. CTLA-4-Fas ligand functions as a trans signal converter protein in bridging antigen-presenting cells and T cells. Int Immunol. 2001 Apr; 13(4):529-39. PMID: 11282992.
      View in: PubMed
    29. Premkumar DR, Fukuoka Y, Sevlever D, Brunschwig E, Rosenberry TL, Tykocinski ML, Medof ME. Properties of exogenously added GPI-anchored proteins following their incorporation into cells. J Cell Biochem. 2001; 82(2):234-45. PMID: 11527149.
      View in: PubMed
    30. Riely GJ, Rachmilewitz J, Koo PH, Tykocinski ML. alpha2-macroglobulin modulates the immunoregulatory function of the lipocalin placental protein 14. Biochem J. 2000 Oct 15; 351 Pt 2:503-8. PMID: 11023837.
      View in: PubMed
    31. Banet G, Bibi O, Matouk I, Ayesh S, Laster M, Kimber KM, Tykocinski M, de Groot N, Hochberg A, Ohana P. Characterization of human and mouse H19 regulatory sequences. Mol Biol Rep. 2000 Sep; 27(3):157-65. PMID: 11254105.
      View in: PubMed
    32. Geho DH, Fayen JD, Jackman RM, Moody DB, Porcelli SA, Tykocinski ML. Glycosyl-phosphatidylinositol reanchoring unmasks distinct antigen-presenting pathways for CD1b and CD1c. J Immunol. 2000 Aug 1; 165(3):1272-7. PMID: 10903726.
      View in: PubMed
    33. Chen A, Zheng G, Tykocinski ML. Hierarchical costimulator thresholds for distinct immune responses: application of a novel two-step Fc fusion protein transfer method. J Immunol. 2000 Jan 15; 164(2):705-11. PMID: 10623813.
      View in: PubMed
    34. Fayen JD, Tykocinski ML, Medof ME. Glycerolphosphoinositide anchors for membrane-tethering proteins. Methods Enzymol. 2000; 327:351-68. PMID: 11044996.
      View in: PubMed
    35. Brunschwig EB, Fayen JD, Medof ME, Tykocinski ML. Protein transfer of glycosyl-phosphatidylinositol (GPI)-modified murine B7-1 and B7-2 costimulators. J Immunother. 1999 Sep; 22(5):390-400. PMID: 10546154.
      View in: PubMed
    36. Tanos V, Prus D, Ayesh S, Weinstein D, Tykocinski ML, De-Groot N, Hochberg A, Ariel I. Expression of the imprinted H19 oncofetal RNA in epithelial ovarian cancer. Eur J Obstet Gynecol Reprod Biol. 1999 Jul; 85(1):7-11. PMID: 10428315.
      View in: PubMed
    37. Rachmilewitz J, Riely GJ, Tykocinski ML. Placental protein 14 functions as a direct T-cell inhibitor. Cell Immunol. 1999 Jan 10; 191(1):26-33. PMID: 9918684.
      View in: PubMed
    38. Weber MC, Groger RK, Tykocinski ML. Antisense modulation of the ICAM-1 phenotype of a model human bone marrow stromal cell line. Exp Cell Res. 1998 Oct 10; 244(1):239-48. PMID: 9770366.
      View in: PubMed
    39. Miller RE, Fayen JD, Chakraborty S, Weber MC, Tykocinski ML. A receptor for the lipocalin placental protein 14 on human monocytes. FEBS Lett. 1998 Oct 9; 436(3):455-60. PMID: 9801168.
      View in: PubMed
    40. Fayen J, Huang JH, Ferrone S, Tykocinski ML. Negative signaling by anti-HLA class I antibodies is dependent upon two triggering events. Int Immunol. 1998 Sep; 10(9):1347-58. PMID: 9786434.
      View in: PubMed
    41. Rachmilewitz J, Tykocinski ML. Differential effects of chondroitin sulfates A and B on monocyte and B-cell activation: evidence for B-cell activation via a CD44-dependent pathway. Blood. 1998 Jul 1; 92(1):223-9. PMID: 9639520.
      View in: PubMed
    42. Chen A, Meyerson HJ, Salvekar A, Tykocinski ML. Non-glycosylated human B7-1(CD80) retains the capacity to bind its counter-receptors. FEBS Lett. 1998 May 29; 428(3):127-34. PMID: 9654121.
      View in: PubMed
    43. Muschel RJ, Tykocinski M, Padarathsingh M. Link between tumor progression, proteases, and cell motility. Pathology B workshop. Am J Pathol. 1996 Sep; 149(3):1073-6. PMID: 8780409.
      View in: PubMed
    44. Meyerson HJ, Huang JH, Fayen JD, Tsao HM, Getty RR, Greenspan NS, Tykocinski ML. Functional dissociation of CD8 alpha's Ig homologue and connecting peptide domains. J Immunol. 1996 Jan 15; 156(2):574-84. PMID: 8543808.
      View in: PubMed
    45. Tykocinski ML, Kaplan DR, Medof ME. Antigen-presenting cell engineering. The molecular toolbox. Am J Pathol. 1996 Jan; 148(1):1-16. PMID: 8546197.
      View in: PubMed
    46. Tykocinski ML, Xiong N, Morrow DM. Platelet immunoregulatory factors. Stem Cells. 1996; 14 Suppl 1:240-5. PMID: 11012227.
      View in: PubMed
    47. Brunschwig EB, Levine E, Trefzer U, Tykocinski ML. Glycosylphosphatidylinositol-modified murine B7-1 and B7-2 retain costimulator function. J Immunol. 1995 Dec 15; 155(12):5498-505. PMID: 7499830.
      View in: PubMed
    48. Matrisian LM, Tykocinski ML, Padarathsingh M. Lessons to be learned from hematopoietic malignancies. Workshop report from the Division of Research Grants, National Institutes of Health. Am J Pathol. 1995 Nov; 147(5):1519-21. PMID: 7485414.
      View in: PubMed
    49. Fayen J, Huang JH, Meyerson H, Zhang D, Getty R, Greenspan N, Tykocinski M. Class I MHC alpha 3 domain can function as an independent structural unit to bind CD8 alpha. Mol Immunol. 1995 Mar; 32(4):267-75. PMID: 7723772.
      View in: PubMed
    50. Morrow DM, Xiong N, Getty RR, Ratajczak MZ, Morgan D, Seppala M, Riittinen L, Gewirtz AM, Tykocinski ML. Hematopoietic placental protein 14. An immunosuppressive factor in cells of the megakaryocytic lineage. Am J Pathol. 1994 Dec; 145(6):1485-95. PMID: 7992851.
      View in: PubMed
    51. Huang JH, Getty RR, Chisari FV, Fowler P, Greenspan NS, Tykocinski ML. Protein transfer of preformed MHC-peptide complexes sensitizes target cells to T cell cytolysis. Immunity. 1994 Oct; 1(7):607-13. PMID: 7600289.
      View in: PubMed
    52. Huang JH, Greenspan NS, Tykocinski ML. Alloantigenic recognition of artificial glycosyl phosphatidylinositol-anchored HLA-A2.1. Mol Immunol. 1994 Sep; 31(13):1017-28. PMID: 8084336.
      View in: PubMed
    53. Weber MC, Tykocinski ML. Bone marrow stromal cell blockade of human leukemic cell differentiation. Blood. 1994 Apr 15; 83(8):2221-9. PMID: 7512844.
      View in: PubMed
    54. Singh N, Zoeller RA, Tykocinski ML, Lazarow PB, Tartakoff AM. Addition of lipid substituents of mammalian protein glycosylphosphoinositol anchors. Mol Cell Biol. 1994 Jan; 14(1):21-31. PMID: 8264589.
      View in: PubMed
    55. Weber MC, Groger RK, Tykocinski ML. A glycosylphosphatidylinositol-anchored cytokine can function as an artificial cellular adhesin. Exp Cell Res. 1994 Jan; 210(1):107-12. PMID: 8269987.
      View in: PubMed
    56. Liang X, Tang M, Zamb TJ, Babiuk LA, Kowalski J, Tykocinski ML. Expression of glycoprotein gIII-human decay-accelerating factor chimera on the bovine herpesvirus 1 virion via a glycosyl phosphatidylinositol-based membrane anchor. J Virol. 1993 Aug; 67(8):4896-904. PMID: 7687305.
      View in: PubMed
    57. Hambor JE, Kaplan DR, Tykocinski ML. CD8 functions as an inhibitory ligand in mediating the immunoregulatory activity of CD8+ cells. J Immunol. 1990 Sep 15; 145(6):1646-52. PMID: 1697305.
      View in: PubMed
    58. Hambor JE, Weber MC, Tykocinski ML, Kaplan DR. Regulation of allogeneic responses by expression of CD8 alpha chain on stimulator cells. Int Immunol. 1990; 2(9):879-83. PMID: 2149069.
      View in: PubMed
    59. Kaplan DR, Hambor JE, Tykocinski ML. An immunoregulatory function for the CD8 molecule. Proc Natl Acad Sci U S A. 1989 Nov; 86(21):8512-5. PMID: 2510168.
      View in: PubMed
    60. Hambor JE, Tykocinski ML, Kaplan DR. Functional consequences of anti-sense RNA-mediated inhibition of CD8 surface expression in a human T cell clone. J Exp Med. 1988 Oct 1; 168(4):1237-45. PMID: 2459296.
      View in: PubMed
    61. Tykocinski ML, Shu HK, Ayers DJ, Walter EI, Getty RR, Groger RK, Hauer CA, Medof ME. Glycolipid reanchoring of T-lymphocyte surface antigen CD8 using the 3' end sequence of decay-accelerating factor's mRNA. Proc Natl Acad Sci U S A. 1988 May; 85(10):3555-9. PMID: 2453063.
      View in: PubMed
    62. Werber HI, Emancipator SN, Tykocinski ML, Sedor JR. The interleukin 1 gene is expressed by rat glomerular mesangial cells and is augmented in immune complex glomerulonephritis. J Immunol. 1987 May 15; 138(10):3207-12. PMID: 2883234.
      View in: PubMed
    63. Tykocinski ML, Marche PN, Max EE, Kindt TJ. Rabbit class I MHC genes: cDNA clones define full-length transcripts of an expressed gene and a putative pseudogene. J Immunol. 1984 Oct; 133(4):2261-9. PMID: 6432910.
      View in: PubMed
    Tykocinski's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (339) concept(s)
    _
    Co-Authors Expand Description
    See all (7) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department
    Physical Neighbors Expand Description
    _